Last €1.49 EUR
Change Today +0.018 / 1.22%
Volume 51.5K
ISG On Other Exchanges
Symbol
Exchange
BrsaItaliana
BrsaItaliana
As of 11:30 AM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

isagro spa (ISG) Snapshot

Open
€1.48
Previous Close
€1.48
Day High
€1.53
Day Low
€1.48
52 Week High
04/3/14 - €2.76
52 Week Low
01/15/15 - €1.36
Market Cap
53.9M
Average Volume 10 Days
31.0K
EPS TTM
€0.17
Shares Outstanding
24.5M
EX-Date
05/28/12
P/E TM
8.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for ISAGRO SPA (ISG)

Related News

No related news articles were found.

isagro spa (ISG) Related Businessweek News

No Related Businessweek News Found

isagro spa (ISG) Details

Isagro S.p.A., together with its subsidiaries, is engaged in the research, management, development, manufacture, marketing, and distribution of agrochemicals for crop protection worldwide. Its products include fungicides, insecticides, pheromones, biostimulants, and biological fungicides. The company is based in Milan, Italy. Isagro S.p.A. is a subsidiary of Holdisa S.r.l.

isagro spa (ISG) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: €502.7K
General Director of Operations
Total Annual Compensation: €4.6K
Head of Corporate Development and Internal Re...
Total Annual Compensation: €5.8K
Compensation as of Fiscal Year 2013.

isagro spa (ISG) Key Developments

Isagro S.p.A. Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Sales Guidance for the Fourth Quarter and Earnings Guidance for the Full Year of 2014

Isagro S.p.A. reported consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company's revenues from sales and services was EUR 29,369,000 compared to EUR 24,020,000 a year ago. EBITDA excl. non recurrent income was EUR 798,000 compared to loss of EUR 641,000 a year ago. EBITDA was EUR 798,000 compared to loss of EUR 641,000 a year ago. LBIT was EUR 1,347,000 compared to EUR 2,975,000 a year ago. Loss before taxes was EUR 1,915,000 compared to EUR 3,928,000 a year ago. Net loss from continuing operations was EUR 1,904,000 compared to EUR 1,658,000 a year ago. Net loss was EUR 1,904,000 compared to EUR 1,658,000 a year ago. For the nine months, the company's revenues from sales and services was EUR 102,303,000 compared to EUR 84,717,000 a year ago. EBITDA excl. non recurrent income costs was EUR 7,698,000 compared to EUR 905,000 a year ago. EBITDA was EUR 7,698,000 compared to EUR 905,000 a year ago. EBIT was EUR 1,220,000 compared to LBIT of EUR 6,289,000 a year ago. Loss before taxes was EUR 1,088,000 compared to EUR 9,812,000 a year ago. Net loss from continuing operations was EUR 1,138,000 compared to EUR 8,306,000 a year ago. Net loss was EUR 1,138,000 compared to EUR 8,306,000 a year ago. The results of the first nine months of 2014 have been characterized by the recovery of sales versus 2013 (a year which was negatively affected by the "carried-over" effect of 2012 drought) and by the start of the commercial cooperation with the partner Gowan in USA and in Italy; such elements more than offset a weakening of Group's sales in Brazil and lower sales of Orthosulfamuron and Valiphenalate (the latter two molecules divested in 2013). Cash flow from operations was EUR 8,926,000 compared to cash flows used in operations of EUR 2,041,000 a year ago. Investments in intangible assets was EUR 7,873,000 compared to EUR 6,588,000 a year ago. Investments in tangible assets was EUR 3,104,000 compared to EUR 1,459,000 a year ago. Net financial debt was EUR 27.3 million compared to EUR 63.9 million as of September 30th, 2013. Furthermore, sales in fourth quarter of the current year are expected to be lower than fourth quarter 2013 ones, due to reduced year-end purchases by the distribution systems in Brazil (due to consumption of existing stock and to a weakening of market conditions for Isagro's products) and in Italy (to limit year-end stocks). For the whole year 2014 the company forecasts: Revenues from products and services substantially in line with the EUR 144 million of the Business Plan; Revenues from Licensing of EUR 2 million versus the EUR 8 million of the Business Plan (confirming the objective of the Business Plan of realizing, in the 2014-2018 period, total revenues of EUR 13 million, even if with a different timing in the single years); EBITDA around EUR 11 million versus the EUR 14.8 million of the Business Plan (due to lower Licensing for EUR 6 million); Result before taxes not far from break-even.

Isagro S.p.A. Presents at London Star Conference 2014, Oct-03-2014

Isagro S.p.A. Presents at London Star Conference 2014, Oct-03-2014 . Venue: London Stock Exchange, 10 Paternoster Square, London EC4M 7LS, United Kingdom.

Isagro S.p.A. Reports Consolidated Earnings Results for the First Half Year Ended June 30, 2014; Provides Earnings Guidance for the Year 2014

Isagro S.p.A. reported consolidated earnings results for the first half year ended June 30, 2014. For the period, the company reported revenues of EUR 72.9 million compared to EUR 60.7 million reported in the same period last year. EBITDA was EUR 6.9 million against EUR 1.5 million reported last year. EBIT was EUR 2.6 million against EBIT loss of EUR 3.3 million reported last year. Profit before taxes was EUR 0.8 million against loss before tax of EUR 5.9 million reported last year. Net profit from continuing operations was EUR 0.77 million against loss from continuing operations of EUR 6.6 million reported last year. Net profit was EUR 0.8 million against net loss of EUR 6.6 million reported last year. Cash flow from operating activities was EUR 5.7 million against EUR 2.4 million reported last year. Investments in tangible assets were EUR 1.6 million against EUR 1.0 million reported last year. Also in the light of the achievement of 2014 first half expected results, the company confirmed the reasonableness of the targets of revenues around EUR 150 million and EBITDA around EUR 15 million set for the year 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISG:IM €1.49 EUR +0.018

ISG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BASF SE €77.35 EUR -0.41
Bayer AG €128.21 EUR -1.30
Syngenta AG SFr.293.90 CHF +2.00
View Industry Companies
 

Industry Analysis

ISG

Industry Average

Valuation ISG Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 2.8x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISAGRO SPA, please visit www.isagro.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.